Quintiles.com

  • Therapeutic Expertise Oncology

  • clinical-trials-header
  • Quintiles Clinical Trial

    New oncology therapies must overcome some of the lowest approval rates in biopharma.

    To realize your product’s potential, work with the most experienced CRO in oncology development. Knowledgeable in virtually every major cancer indication, our oncology specialists combine scientific and medical expertise with commercial strategies to optimize your product’s success.

    Our fully integrated approach to oncology development extends across the product lifecycle, offering you expertise in:

    • Clinical development – Supporting 900+ oncology trials over the past decade with the right infrastructure and quality systems.
    • Regulatory – Global and regional experts with FDA, European, Japanese and other regulatory backgrounds.
    • Commercialization – 68 oncology-specific teams to assess your product’s commercial viability and maximize market success.
    • Market Access – Validate the efficacy and price point of your oncology treatment to gain formulary access.
    • Risk-sharing – Innovative models to ease your upfront investment and build portfolio value.

  • More expertise in oncology therapies than any other CRO

  • Quintiles Clinical Trails

    Setting the right course early in oncology development is critical.  In a webcast archive, leading oncology experts  provide insights into the current R&D challenges in oncology and key success criteria for Phase I oncology studies.  Download the webcast

  • Quintiles Clinical Trails

    Quintiles can help you map stakeholder requirements and integrate these into the development process from the very beginning, incorporating critical endpoints to drive more efficient clinical trials. Watch Video